These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1258 related items for PubMed ID: 14739306

  • 1. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR.
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA.
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [Abstract] [Full Text] [Related]

  • 3. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [Abstract] [Full Text] [Related]

  • 4. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA.
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [Abstract] [Full Text] [Related]

  • 5. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN, Francis IR, Herfkens RJ, Jeffrey RB, Glazer GM, Foo TK, Shimakawa A, Pelc NJ.
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [Abstract] [Full Text] [Related]

  • 6. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O.
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [Abstract] [Full Text] [Related]

  • 7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 8. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
    Kondo H, Kanematsu M, Itoh K, Ito K, Maetani Y, Goshima S, Matsuo M, Matsunaga N, Konishi J, Hoshi H, Moriyama N.
    Magn Reson Imaging; 2005 Jan; 23(1):89-95. PubMed ID: 15733793
    [Abstract] [Full Text] [Related]

  • 11. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 12. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement.
    Chang SD, Thoeni RF.
    AJR Am J Roentgenol; 2008 May; 190(5):1318-23. PubMed ID: 18430850
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
    Coulam CH, Chan FP, Li KC.
    AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liver lesion conspicuity: T2-weighted breath-hold fast spin-echo MR imaging before and after gadolinium enhancement--initial experience.
    Jeong YY, Mitchell DG, Holland GA.
    Radiology; 2001 May; 219(2):455-60. PubMed ID: 11323472
    [Abstract] [Full Text] [Related]

  • 18. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
    Le Moigne F, Durieux M, Bancel B, Boublay N, Boussel L, Ducerf C, Berthezène Y, Rode A.
    Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.